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Abstract
Primary Sjo ¨gren’s Syndrome (PSS) is a highly prevalent autoimmune disease, typically manifesting as lymphocytic infiltration
of the exocrine glands leading to chronically impaired lacrimal and salivary secretion. Sjo ¨gren’s Syndrome nuclear
autoantigen 1 (SSNA1 or NA14) is a major specific target for autoantibodies in PSS but the precise function and clinical
relevance of this protein are largely unknown. Orthologues of the gene are absent from many of the commonly used model
organisms but are present in Chlamyodomonas reinhardtii (in which it has been termed DIP13) and most protozoa. We
report the functional characterisation of the orthologue of SSNA1 in the kinetoplastid parasite, Trypanosoma brucei. Both
TbDIP13 and human SSNA1 are small coiled-coil proteins which are predicted to be remote homologues of the actin-
binding protein tropomyosin. We use comparative proteomic methods to identify potential interacting partners of TbDIP13.
We also show evidence that TbDIP13 is able to self-assemble into fibril-like structures both in vitro and in vivo, a property
which may contribute to its immunogenicity. Endogenous TbDIP13 partially co-localises with acetylated a-tubulin in the
insect procyclic stage of the parasite. However, deletion of the DIP13 gene in cultured bloodstream and procyclic stages of
T. brucei has little effect on parasite growth or morphology, indicating either a degree of functional redundancy or a
function in an alternative stage of the parasite life cycle.
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Introduction
Primary Sjo ¨gren’s Syndrome (PSS) is a highly prevalent autoi-
mmune disease, affecting an estimated 0.5% of the population of
the Western World. Key features of this chronic disorder are
lymphocytic infiltration of the exocrine glands leading to impaired
lacrimal and salivary secretion, and the production of autoanti-
bodies. Extraglandular manifestations are common and the risk of
Non-Hodgkin’s lymphoma is 44-fold higher than in healthy
individuals [1]. Despite its high prevalence, PSS has been neg-
lected in terms of research and the multifaceted mechanisms
leading to pathogenesis remain poorly understood.
The human protein Sjo ¨gren’s Syndrome nuclear autoantigen 1
(SSNA1, also known as NA14) is a major specific target for
autoantibodies in PSS [2,3] but the precise function and clinical
relevance of this protein are largely unknown. SSNA1 is a small
protein (13 kDa) with a high coiled-coil content and has been
found on primary cilia, basal bodies, centrosomes and at the
plasma membrane [4,5,6,7]. The protein has been identified as a
binding partner of the microtubule-severing protein spastin, a
member of the AAA ATPase family, which is encoded by the SPG4
gene [8]. Mutations in the SPG4 gene are implicated in
approximately 40% of cases of the genetic disorder hereditary
spastic paraplegia (HSP) [9]. SSNA1 has also been identified as a
binding partner for the G-protein coupled receptor TPRA40, the
expression of which is rapidly downregulated during hypoxia and
reoxygenation in mammals [6].
Orthologues of SSNA1 are absent from the common eukaryotic
model systems Saccharomyces cerevisiae, Caenorhabditis elegans and
Drosophila melanogaster but are encoded by the genomes of the
flagellated green alga Chlamydomonas reinhardtii, trematode worms
(Schistosoma spp.) and protozoan parasites [4]. The C. reinhardtii
orthologue of SSNA1 (known as Deflagellation Inducible Protein
13 or DIP13) was identified as the product of an upregulated
transcript following mechanical deflagellation. DIP13 has a similar
cellular distribution to SSNA1, localising to microtubules (MTs) in
the flagellar axoneme, basal bodies and cytoplasm [4,10].
Knockdown of the DIP13 transcript by antisense expression
results in the production of cells with multiple nuclei and flagella
[4], while over-expression of a GFP-tagged form of DIP13 causes a
defect in the assembly of full-length flagella, correlating with a
marked decrease in the rate of flagellar regeneration following
mechanical deflagellation [10]. Further, a recent study utilising
siRNA high-content screening reported that knockdown of SSNA1
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significantly inhibited the ciliary localisation of signalling cargo
molecules Gli3 and GFP-tagged SMO [7]. GFP-tagged SSNA1
was localised to the centrosome in all cell types analysed in the
study and additionally, to the basal body in ciliated cells [7]. These
data indicate that SSNA1/DIP13 may have more than one role in
cell division and ciliary function.
In the current study, we report the characterisation of the
SSNA1/DIP13 orthologue (which we have termed TbDIP13) in
the protozoan parasite Trypanosoma brucei. The parasite protein is
predicted to assume a largely coiled-coil configuration and
demonstrates a striking ability to assemble into fibril-like structures
under physiological conditions, both in vivo and in vitro. This
intrinsic property may contribute to immunogenicity, both of the
trypanosome protein in the bloodstream of the infected host and
also of the human protein as an autoantigen. Further, an antibody
response to TbDIP13 can be detected in human African
trypanosomiasis (HAT) patients with circulating bloodstream form
parasites, raising the possibility of a parasite-induced autoimmune
response during infection. We report that TbDIP13 partially co-
localises with acetylated a-tubulin in trypanosomes and we identify
a number of potential interacting partners by the use of
comparative proteomics (iTRAQ). Deletion of both alleles of the
gene by homologous recombination in bloodstream and procyclic
form parasites has little effect on cell growth or morphology,
suggesting either a degree of functional redundancy or a function
in an alternative stage of the parasite life cycle.
Results
Identification of a T. brucei DIP13 orthologue
As part of an ongoing study on N-myristoylated proteins in
kinetoplastids, we identified a protein sequence encoded by the T.
brucei brucei genome (Tb10.61.2720 from GeneDB Version 2.1), of
which the C-terminus shared 33% identity with the Chlamydomonas
reinhardtii flagellar protein DIP13 [11]. Regions of this sequence
were also detected in studies to identify components of the T. brucei
flagellar proteome [12,13]. The annotated 22 kDa protein had a
predicted N-myristoylation site and an extended N-terminus
compared to other orthologues but further analysis revealed that
the wrong start codon had been assigned to this gene in the T. b.
brucei genome sequence (described in detail in Figure S1). The
corrected ORF encodes a protein of 13.2 kDa and pI 8.0 with no
predicted N-terminal modifications but extensive coiled-coil
regions covering over 70% of the sequence (Figure S1C).
Overexpression of TbDIP13 in BSF parasites
In order to investigate the subcellular localization of TbDIP13,
C-terminal epitope-tagged forms of TbDIP (TbDIP13
GFP and
TbDIP13
myc) were overexpressed using a tetracycline-inducible
system in T. brucei bloodstream form (BSF) parasites (Figure 1A–
D). It should be noted that the overexpression constructs were
designed prior to splice-site mapping (see above) and contained a
vector-derived trans-splice site, the accurate TbDIP13 ORF with a
C-terminal tag and an additional upstream region including the
originally annotated start codon. Therefore there was a risk that an
anomalous protein would be expressed. However, splice-site
mapping following tetracycline induction of expression revealed
that the parasites exclusively used the same splice site for the over-
expressed transcript as for the endogenous transcript, thereby
generating the template for the correct protein (Figure S1).
TbDIP13
GFP in BSF cells consistently localized to a long thin
internal structure stretching from the far posterior end of the cell
to a region close to the late endosomes (Figure 1C, D). There was
no obvious association with the early endosomes (Figure 1B),
paraflagellar rod, acidocalcisomes or glycosomes (data not shown).
The mean length of the structure was 4.97 mm( +/2 s.d. 1.36,
n=100) with an absolute range of 2.81–10.87 mm. The myc-
tagged form of TbDIP (TbDIP13
myc) had an identical localisation
pattern (Figure S1D) showing that this unusual localisation was not
caused by GFP aggregation. Further, full-length structures
containing TbDIP13
GFP were visible in cells from 1 hour post-
induction of expression and could be visualised by video
microscopy in live cells (data not shown). Surprisingly, localisation
of the protein appeared to be asymmetrical in a majority of cells
(,90%) in the late stages of cytokinesis, with a single filament
evident in only one of the two daughter cells (Figure 1E). In a
minor population of cells undergoing cytokinesis, the TbDIP13
structure was found at the site of abscission (Figure 1F), although
the significance of this is not clear.
The majority of TbDIP13
GFP protein was highly insoluble and
resistant to detergent extraction, remaining associated with the
cytoskeleton following treatment with 1% NP40 and 1 M salt
(Figure S2 and data not shown). Detergent-extracted cytoskeletons
from cells over-expressing TbDIP13
GFP were probed with an anti-
GFP antibody and observed by scanning electron microscopy to
analyse the localization and origins of the novel structure at a
higher resolution (Figure S2). TbDIP13 was uniformly distributed
throughout the structure, which closely associated with the
parasite cytoskeleton and appeared to be linked to the base of
the flagellum. There was no significant effect on overall mor-
phology or cell growth in TbDIP13
GFP expressing cells grown in
the presence of tetracycline over a 5-day time course (Figure S3
and data not shown). Expression of TbDIP13
GFP was also
attempted in PCF cells but no exogenous protein could be
detected (data not shown).
Localisation Studies using TbDIP13 Antibody
Polyclonal antibodies against the C. reinhardtii and human
orthologues of SSNA1/DIP13 [2,4] recognised multiple bands on
immunoblots of T. brucei parasite lysates (data not shown) and so
were unsuitable for TbDIP13 subcellular localisation studies.
Therefore, we raised a polyclonal antibody against full-length
recombinant TbDIP13 protein expressed in E. coli. Affinity-purified
antibody was first used to analyse the subcellular location of
overexpressed TbDIP13 without an epitope tag (TbDIP13
NoTag). In
contrasttotaggedprotein,TbDIP13
NoTagwasdetectedinanumber
of long structures spanning the cell body (Figure 1G, H) which
partially co-localised with a-tubulin (Figure 1H) consistent with an
association with the cytoskeleton. However, endogenous TbDIP13
was detected in the BSF parental cell line in a diffuse punctate
pattern, together with dense staining of a small region adjacent to
the kinetoplast (Figure 1I). Staining of the diffuse punctate pattern
was lost in TbDIP13 null cell lines whereas the small intense region
was retained (Figure 1J).
Our data for BSF cells therefore suggest that overexpressed
TbDIP13 with the C-terminus blocked by an epitope tag
oligomerises in a highly consistent manner to produce a single
stable extraneous structure within the cell. In the absence of an
epitope tag, TbDIP13 is seen on several long structures, indicating
either the production of multiple extraneous structures such as that
described above or binding of the protein to existing components
of the cytoskeleton. In contrast, the endogenous protein is detected
in a punctate pattern, suggesting either that oligomerisation does
not occur at the normal intracellular concentration of the protein
or that the observed puncta represent nucleating centres from
which fine filaments radiate, which are undetectable by indirect
immunofluorescence.
SSNA1/DIP13 in Trypanosoma brucei
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endogenous TbDIP13 was found only in a subset of T. brucei
procyclic form (PCF) cells with one nucleus and two kinetoplasts
(i.e. in the early stages of mitosis). The protein was detected in a
punctate pattern following one or more discrete lines which
partially co-localised with acetylated a-tubulin (Figure 1K, L), as
previously observed for C. reinhardtii DIP13 [4]. No equivalent
staining with anti-TbDIP13 was seen in BSF parasites, suggesting
a differential localisation of the protein in these two life cycle
stages.
SSNA1/DIP13 are remote homologues of tropomyosin
The protein structures of TbDIP13 and its orthologues in
humans, Chlamydomonas and the protozoan Leishmania major were
predicted using the Phyre server [14,15] which combines a
number of prediction programs and methods to identify remote
homologues, predict secondary structure and build 3D models of
a query sequence. All four of the SSNA1/DIP13 orthologues were
predicted with high precision values (e.g. E-value of 3.5e-09
for human SSNA1) to be remote homologues of the actin-binding
protein tropomyosin. Tropomyosin exists as a dimer of two
Figure 1. Subcellular localisation of DIP13 in T. brucei. (A–D) Fluorescence analysis of T. brucei bloodstream form (BSF) transgenic line 427/
pTbDIP13GFP grown in the presence of tetracycline for 24 hours. (A, C) Cells were prestained with Texas Red conjugated ConA (red) at 4uC to stain
the flagellar pocket, FP (A) or at 37uC to stain the FP and endosomes (C). (B, D) Cells were probed with antibodies against the early endosome (EE)
marker Rab5 (B) or a-tubulin (D). (E, F) Fluorescence analysis of T. brucei bloodstream form (BSF) transgenic line 427/pTbDIP13GFP (24 hours post-
induction) undergoing cytokinesis, with corresponding DIC images. (G–J) Immunofluorescence analysis of transgenic line 427/ pTbDIP13
NoTag grown
in the presence of tetracycline for 24 hours (G, H), BSF parental line Lister 427 (I) and DIP13 double knockout line (J), all probed with purified rabbit
anti-TbDIP13 (green). The cell shown in (H) was also probed with anti-a-tubulin (red) and regions of co-localisation are indicated by arrows. (K, L)
Immunofluorescence analysis of T. brucei procyclic form (PCF) parental line EATRO 1125 probed with purified rabbit anti-TbDIP13 (green) and anti-
acetylated a-tubulin (red) All cells were co-stained with DAPI (blue). Kinetoplasts are indicated by arrows. Bar, 5 mm.
doi:10.1371/journal.pone.0031842.g001
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head-to-tail arrangement to form a long flexible rope-like filament
[16]. The SSNA1/DIP13 orthologues were predicted to consist
largely of a-helical coiled-coil with a short disordered region (,20
amino acids) at the C-terminus. A 3D model of TbDIP13
(Figure 2A, B) predicts that the protein assumes a highly regular
rod-like structure composed of a tightly wound parallel 2-strand
coiled-coil, closely matching the known structure of tropomyosin
despite low sequence identity between the two (14.8% at the
amino acid level with human tropomyosin). These data therefore
support our hypothesis that TbDIP may exist as a stable
homodimer with the ability to oligomerise into filaments.
In order to produce direct evidence of homo-oligomerisation,
purified recombinant TbDIP
His was incubated in a neutral pH
buffer at 37uC overnight before analysis by negative stain trans-
mission electron microscopy. The protein was clearly shown to
self-assemble into filament-like structures reminiscent of amyloid
fibrils (Figure 2C–F). The majority of these structures were
approximately 10–15 nm wide and several thousand nm long. In
addition to single filaments, coiled pairs of filaments were visible
(Figure 2E) which may reflect the ability of the protein to bundle
into larger structural components. The intrinsic properties of this
oligomer-forming coiled-coil protein suggest that it may play a role
in the assembly of filamentous structures.
DIP13 is not essential for viability in T. brucei
RNA interference of DIP13 was performed in T. brucei BSF but
only partial knockdown (,50%) was achieved by 24 hours and no
phenotype was observed (data not shown). As an alternative
approach, BSF and PCF null mutant strains were produced by
homologous recombination (Figures 3 and 4), replacing both
alleles of the DIP13 gene with antibiotic resistance markers,
resulting in the genotype Ddip13::BLE/Ddip13::PAC (Figures 3A,
3B and 4A). Double knockout lines were cloned by limiting
dilution and tested for traces of DIP13 DNA by the highly sensitive
method of quantitative PCR (data not shown). Southern blots to
confirm correct integration of the antibiotic resistance genes and
presence/absence of DIP13 are shown in Figures 3B and 4A. The
DIP13 probe hybridises to fragments of 4.4 and 1.2 kb in the BSF
and PCF parental lines, with an additional band of approximately
5.5 kb in PCF which may correspond to partially digested DNA
(Figure 4A). These bands are absent in the double knockout lines
as expected. The BLE probe hybridises to a band of 5 kb in the
double knockout cells and the PAC gene is found on a fragment of
4.8 kb in this line. Neither of these antibiotic resistance genes are
detected in the parental line as expected but the PAC probe
hybridises to additional cross-reacting fragments of 11 and 10 kb
in both parental and knockout BSF lines, which may be due to
non-specific cross-hybridisation with another region of the genome
(Figure 3A).
Immunoblotting using anti-TbDIP13 demonstrates the loss of a
13 kDa band in the TbDIP13 BSF null line, with anti-EF-1a used
as a constitutive loading control (Figure 3C). The anti-TbDIP13
antibody cross-reacts with an additional 22 kDa protein in both
parental and null lines, which may represent the same molecule
detected in a small intense region of the TbDIP13 null cells by
immunofluorescence (Figure 1J).
No protein bands were detected in PCF cell lysates using anti-
TbDIP13 (data not shown), which correlates with the small subset
of cells found to express the protein by immunofluorescence
analysis. As expected, no staining was detected when PCF cells
from the knockout line were probed with the anti-TbDIP13
antibody (data not shown).
Deletion of both alleles of the DIP13 gene had no significant
effect on cell growth, as monitored over a 5-day period in BSF and
PCF stage T. brucei (Figures 3D and 4B). Parasites showed normal
motility (data not shown) and had no gross morphological defects
as visualised by confocal and scanning electron microscopy
(Figures 3E, F and 4E). Cells were stained with specific antibodies
against total and acetylated a-tubulin, as a previous report
suggested that C. reinhardtii DIP13 may be preferentially associated
with acetylated microtubules [4]. No differences were observed
between parental and TbDIP13 null lines in tubulin staining
patterns and gross cell morphology (Figure 3E and data not
shown). An antibody recognising paraflagellar rod proteins 1 and 2
produced more extensive staining in the TbDIP13 null line
(Figure 3E), with the emergence of a punctate pattern in addition
to the characteristic PFR staining pattern. PFR1 and 2 are coiled-
coil proteins and it is conceivable that in the null mutant line they
are able to bind with low-specificity to structures or complexes
instead of the absent TbDIP13 protein. However, no detrimental
effects of this are seen and no structural changes to the flagellum
Figure 2. TbDIP13 protein analysis. (A–B) Molecular model of a
homodimer of T. brucei DIP13, represented by ribbon (A) and sphere (B)
drawings. Protein structural predictions were performed using the
Phyre server and resulting data processed with CCP4mg and Coot
software. The protein is predicted to dimerise to form a classical 2-
strand parallel coiled-coil. (C–F) Transmission electron micrographs of
recombinant TbDIP13 protein, following incubation in neutral pH buffer
at 37uC overnight and staining with uranyl acetate. Bar, 500 nm (C),
200 nm (D, E) or 100 nm (F).
doi:10.1371/journal.pone.0031842.g002
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microscopy(Figures3Fand4E)ortransmissionelectronmicroscopy
(data not shown). Parental and knockout parasites were stained with
antibodies recognising a-tubulin or the paraflagellar rod proteins
PFR1/2 and acquired images were used to measure cell body and
PFR lengths in non-dividing cells (which have one nucleus and one
kinetoplast). The PFR was found to extend to the distal tip of the
flagellum in all cell lines (data not shown) and therefore could be
used as a reliable marker of flagellum length. There was no
significant difference in cell length in TbDIP13 knockout PCF
parasites compared to the parental line (Figure 4C). There was
however, a modest but statistically significant reduction in body
length in the BSF TbDIP13 knockout line (mean value of 13.64 mm
compared to 14.83 mm for the parental line, p=,0.0001)
(Figure 3G). In addition, PFR length was significantly decreased
in the TbDIP13 knockout lines of both life cycle stages compared to
the appropriate parental line (p=,0.05) (Figure 3H and 4D). No
defects in flagellum motility were observed (data not shown). We
therefore conclude that under standard in vitro growth conditions,
TbDIP13 is not essential in BSF and PCF cells for normal growth
andmorphologyexceptforpotentialminor rolesinthe regulationof
cell body and flagellum lengths.
We also tested the ability of the DIP13 null BSF parasite line to
establish an infection in a mouse model (data not shown). Mice
were infected with 2610
5 parasites and levels of parasitaemia
checked at 48 and 72 hours post-infection. By 72 hours, parasite
concentrations in the blood were greater than 5610
7/ml in mice
infected with either the parental or TbDIP13 null line, indicating
that TbDIP13 is not required for the successful establishment of a
murine host infection.
Immune recognition of T. brucei DIP13 in HAT Patients
As the human orthologue of DIP13 is a known autoantigen, we
looked for evidence that TbDIP13 is a dominant antigen in human
African trypanosomiasis (HAT) patients, recognition that could
potentially lead to an autoimmune response. Immunoblots of total
BSF stage parasite lysate and purified recombinant TbDIP13 were
probed with sera from 8 confirmed cases of T. b. rhodesiense
(including both early and late stage disease) and 2 control samples
from Uganda. Response patterns were highly variable and no
single dominant antigen was strongly recognised by all patients.
Antibodies to purified recombinant His-tagged TbDIP13 protein
were detected with variable strength in 7 out of 8 patients but not
in the control samples (Figure 5). The strongest response to
recombinant TbDIP13 was detected in the serum of a HAT
patient from the Tororo focus in SE Uganda, with early stage
disease and a very high blood parasitaemia (wet film parasitaemia
of 20 per 10 fields, 6400 magnification). This patient also
responded strongly to a protein of the correct size (approximately
1 kDa smaller than the His-tagged recombinant protein) in total
parasite lysate (Figure 5). Therefore TbDIP13 appears to be
immunogenic, inducing the production of antibodies in HAT
patients with detectable blood parasitaemia. However, the only
patient sample displaying no anti-TbDIP13 response was from a
late stage case of the disease with negative blood and positive CSF
parasitaemia, implying that the antibody response against
TbDIP13 is transient and characteristic of early infection. Further
studies using a large representative panel of patient sera would be
required to confirm these observations.
Comparative proteomic (iTRAQ) analysis
Interaction studies can be problematic when working with
highly insoluble proteins but here we exploited the ability of
TbDIP13 to form stable insoluble structures, using our T. brucei
BSF lines expressing DIP13
GFP or DIP13
myc as a model system to
identify potential interacting partners of the protein. Human
SSNA1 has been reported to bind to spastin [8] and TPRA40 [6]
but no other binding partners of this protein are known. As
described above, our data indicate that overexpressed TbDIP13
self-assembles into long structures which can be extracted with the
highly insoluble flagellum/basal body components of the cell. We
employed the proteomic non-gel technique isobaric tag for relative
and absolute quantitation (iTRAQ), to identify and compare the
relative amounts of the components of this insoluble fraction in
TbDIP13 overexpressing cells compared to the parental line.
Flagellar extracts were prepared by consecutive detergent and
high salt extraction steps, then redissolved in buffer containing
5 M urea and 0.5% SDS. Protein concentration was measured
and confirmed by SDS-PAGE (Figure S4A). Following iTRAQ
labelling and mass spectrometry, a total of 257 proteins were
identified with at least 1 peptide with an ion score with higher than
95% confidence, representing the first published flagellar pro-
teome of T. brucei BSF cells. No novel proteins were found in the
TbDIP13 overexpressing cell extracts compared to the parental
line. Full lists of identified proteins are provided in Tables S2 and
S3. The data set was filtered to exclude proteins with a pI of 10.2
or greater as these are likely to be ribosomal contaminants (Table
S3). The remaining data set contains 184 proteins, of which 121
have previously been found in the T. brucei PCF flagellar proteome
[12,13] and 63 are novel (Table S2). Included in the novel set of
proteins are a number of expected flagellar components, such as a
kinesin motor subunit (Tb10.61.1750) and dynein light chain
(Tb11.03.0815), in addition to many hypothetical proteins. A
major difference between BSF and PCF parasites is in metabolic
requirements, with BSF entirely dependent on glycolysis for ATP
[17] while PCF can utilise lipids and amino acids, particularly
proline [18]. Several glycolytic enzymes were detected in the BSF
flagellar extracts, possibly representing contamination from
Figure 3. DIP13 Gene Deletion in T. brucei BSF. (A) Schematic diagram of the TbDIP13 locus and the plasmid constructs used for deletion.
Flanking sequences used to generate the targeting vectors are shown. The top panel shows the TbDIP13 locus and the second panel shows the
plasmid constructs used for targeted deletion of the locus by replacement with phleomycin/puromycin resistance genes (BLE/PAC) flanked by the
actin 59 UTR and either the actin 39 UTR (BLE) or the aldolase 39 UTR (PAC). Solid black bars represent fragments used as hybridisation probes. (B)
Southern blot analysis of parental line Lister 427 (WT) and DIP13 double replacement (DKO) parasite lines. Five micrograms of genomic DNA from
each parasite line was digested with SacI, size separated through 0.8% agarose, blotted and hybridised with DIG-labelled DNA probes (,200 bp) as
indicated. Corresponding DNA marker positions are shown (kbp). (C) Total cell lysates (5610
6 cells/lane) from cell lines as in (B) were immunoblotted
and probed with purified anti-TbDIP13 and anti-EF1a to monitor equal sample loading. Corresponding protein marker positions are shown (kDa). (D)
Growth of BSF cell lines as above monitored over a 96 hour time course. Mean values are shown (n=3) +/2 SD (not all error bars are visible). (E)
Immunofluorescence analysis of cell lines as above, probed with mouse monoclonal antibodies against total a-tubulin, TAT1 (a-Tub), acetylated a-
tubulin, 6-11B-1 (Acet-Tub) and paraflagellar rod proteins 1 and 2, L13D6 (PFR1/2), shown in green. The corresponding DIC image is presented for
cells probed with anti-PFR1/2. All cells were co-stained with DAPI (blue). Bar, 5 mm. (F) Scanning electron micrographs of parental (WT) and DIP13
double replacement cell line (DKO). Bar, 2 mm. (G, H) Cell body length (G) and paraflagellar rod length (H) in BSF parental line Lister 427 (WT) and
DIP13 double replacement (DKO) parasite lines. Mean values are shown as horizontal lines (+/2 SD) (n=100). Statistical analyses were performed
using an unpaired t test. Asterisks represent statistical significance compared to the parental line (WT) (*=p,0.05, ***=p,0.001).
doi:10.1371/journal.pone.0031842.g003
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mentalised. In addition, several chaperone proteins were found in
the BSF flagellum extracts, including BiP, DNAJ, HSP60 and
HSP70. While these may also represent contaminants, previous
reports have described subpopulations of abundant chaperones
(including HSP70A and DNAJ) to localise specifically to flagella in
Chlamydomonas and mouse spermatozoa, to associate with the
intraflagellar (IFT) machinery and to have roles in flagellum
assembly and function [19,20,21].
For quantitative analysis of our proteomic data, the number of
peptide events was first plotted against iTRAQ ratios for two
independent experimental replicates (cells expressing TbDIP13-
myc) and for experimental samples vs the parental control (Figure
S4B, C). Based on data obtained for the experimental replicates,
peptides detected in less than 4 events were removed from the
iTRAQ data set. Of the remaining 106 proteins, 45 (in addition to
TbDIP13) were found to be significantly enriched or reduced (P
value,0.05) in at least one of the experimental samples compared
to the parental extract, of which 17 were predicted to contain
coiled-coil domains (Table S4). However, with the exception of
TbDIP13 itself, no proteins were enriched more than 2-fold and
only four (plus TbDIP13) were significantly enriched in all three
Figure 4. DIP13 Gene Deletion in T. brucei PCF. (A) Southern blot analysis of parental line EATRO 1125 (WT) and DIP13 double replacement (DKO)
parasite lines. Five micrograms of genomic DNA from each parasite line was digested with SacI, size separated through 0.8% agarose, blotted and
hybridised with DIG-labelled DNA probes (,200 bp) as indicated. Corresponding DNA marker positions are shown (kbp). (B) Growth of PCF cell lines
as above monitored over a 96 hour time course. Mean values are shown (n=3) +/2 SD (not all error bars are visible). (C, D) Cell body length (C) and
paraflagellar rod length (D) in PCF parental line EATRO 1125 (WT) and DIP13 double replacement (DKO) parasite lines. Mean values are shown as
horizontal lines (+/2 SD) (n=100). Statistical analyses were performed using an unpaired t test. Asterisks represent statistical significance compared
to the parental line (WT) (*=p,0.05). (E) Scanning electron micrographs of parental (WT) and DIP13 double replacement cell line (DKO). Bar, 2 mm.
doi:10.1371/journal.pone.0031842.g004
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control (Table 1). All four of these are included in the published
T. brucei PCF flagellar proteome [12,13] and two are kinetoplastid-
specific hypothetical proteins with no known domains or motifs.
Our data show that a-tubulin was significantly enriched and b-
tubulin significantly reduced (both with extremely low P values) in
the flagellar extracts from overexpressing lines compared to
control, although the biological relevance of these observations is
unclear. The fourth enriched protein is the kinetoplastid-specific
microtubule-associated protein 1 (MARP1), which consists of more
than 50 tandemly arranged 38 kDa repeat units (microtubule-
binding motifs) flanked by short nonrepetitive N- and C-termini
[22]. MARP1 is reported to be one of the major structural
components of the T. brucei cytoskeleton and, like TbDIP13, is
antigenic in the mammalian host [23,24]. MARP1 could provide
the necessary linkage between oligomerised TbDIP13 and cellular
microtubules, unless TbDIP13 is able to bind directly to tubulin.
In addition to the molecules described above, a number of
proteins were identified as enriched or depleted in some but not all
three of the TbDIP13 overexpressing parasite samples (Table S4).
There is a greater likelihood that GFP-fusion proteins will have
impaired folding and functionality compared to proteins bearing
the much smaller myc epitope tag [25], so it is possible that some
interacting partners are able to bind to myc-tagged TbDIP13 but
not to the GFP-tagged isoform. Six proteins were identified as
enriched in both TbDIP13
myc expressing samples but not in the
TbDIP13
GFP extract. These include three coiled-coil containing
hypothetical proteins (Tb927.4.1300, Tb11.02.0210 and Tb927.7.
2650) and a hypothetical protein containing leucine rich repeats
(Tb11.01.8770). The remaining two proteins are a member of
the calpain family of peptidases (Tb927.8.8330) and a hypo-
thetical protein containing a C2 calcium-lipid binding motif
(Tb927.7.3550).
While giving potential clues to DIP13 interactions, these data
need to be interpreted with caution and further studies will be
required to determine whether any of the enriched proteins are
true binding partners of TbDIP13.
Discussion
T. brucei DIP13, as characterised in this study, is a small coiled-
coil protein which partially co-localises with acetylated tubulin in
the insect stage procyclic form of the trypanosome and is able to
self-assemble into filaments similar to its distant homologue,
tropomyosin. Serum samples from patients infected with T. brucei
rhodesiense have detectable levels of anti-TbDIP13 antibodies.
However, deletion of the gene encoding TbDIP13 has little effect
on parasite growth or morphology in either procyclic or blood-
stream form parasites, with the exception of a modest decrease in
cell size and flagellum length. Correlating with these observations,
bloodstream form TbDIP13 null parasites retain the ability to
infect mice.
Alpha-helical coiled-coil motifs are found in an estimated 10%
of all protein sequences [26,27] including structural proteins (e.g.
collagen), SNARE complex subunits, cytoskeletal motor proteins,
transcription factors and numerous other groups [28,29,30,31].
The archetypal coiled-coil protein, tropomyosin, has a highly
regular a-helical structure composed of heptad repeats (denoted a-
b-c-d-e-f-g) in which the first and fourth residues are hydrophobic.
Pairs of tropomyosin molecules wind round each other to produce
coiled-coils which are able to polymerise head-to-tail to form
Table 1. Proteins identified by comparative proteomics (iTRAQ) as enriched in the flagellar extracts of T. brucei BSF cells
overexpressing DIP13.
ACC. NO. NAME MW pI FEATURES GFP/WT PVal Myc1/WT PVal Myc2/WT PVal
Tb10.61.2720 Hypothetical protein (DIP13) 13.2 8.0 Coiled coil 4.253 0.000 5.767 0.000 5.292 0.000
Tb11.50.0001 Hypothetical protein 30.1 9.4 Unknown 1.478 0.000 1.474 0.016 1.736 0.010
Tb10.6k15.1500 Hypothetical protein 45.0 9.2 Unknown 1.263 0.002 1.580 0.000 1.626 0.000
Tb927.1.2400 Alpha tubulin 49.7 4.7 Tubulin, coiled coil 1.196 0.000 1.242 0.000 1.231 0.000
Tb10.406.0560 Microtubule-associated protein 237.4 5.2 Repeats 1.167 0.000 1.420 0.000 1.437 0.000
WT, BSF parental line Lister 427. GFP, cells overexpressing C-terminal GFP tagged DIP13. Myc1 and 2, experimental replicates of cells overexpressing C-terminal myc-
tagged DIP13.
doi:10.1371/journal.pone.0031842.t001
Figure 5. Immune Recognition of TbDIP13 by sera from human
African trypanosomiasis (HAT) patients. Immunoblots were
prepared using T. brucei BSF Lister 427 total cell lysate, Lys (5610
5
cells/lane) and recombinant TbDIP protein, Pr (30 ng/lane). Blots were
probed with serum samples from HAT patients and healthy volunteers,
with one example shown for each. The position of TbDIP13 protein is
indicated by an asterisk. Corresponding protein marker positions are
shown (kDa).
doi:10.1371/journal.pone.0031842.g005
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[16]. Our analyses predict that the orthologues of DIP13/SSNA1
in humans, Chlamydomonas and protozoa are structurally very
similar to tropomyosin and to each other, despite low sequence
identity, and therefore might have the intrinsic ability to assemble
into a filament-like structure when present at sufficient concen-
tration. This latter prediction is validated here both in vitro by
transmission electron microscopy of purified recombinant
TbDIP13 protein and in vivo by visualisation of overexpressed
protein. A single filament was produced in parasites over-
expressing TbDIP13 with a C-terminal epitope tag (either GFP
or myc), which appeared to nucleate from the posterior end of the
cell where it was linked to the cytoskeleton. In comparison, cells
overexpressing untagged TbDIP13 contained a number of DIP13
filaments which partially co-localised to tubulin, suggesting that
the C-terminus may be important for microtubule binding or in
regulating oligomerisation. Endogenous TbDIP13 was detected at
much lower concentration in the parasite and did not produce
visible filaments. Instead, the protein was detectable in a diffuse
punctate pattern in bloodstream form parasites and as specific
puncta co-localising with a subpopulation of acetylated a-tubulin
in insect stage parasites undergoing mitosis. It should be noted that
in most eukaryotes, acetylated tubulin is associated with stable and
not dynamic microtubules [32,33] but this modified form of
tubulin has a widespread distribution in T. brucei in all microtubule
arrays, including the mitotic spindle [34]. The TbDIP13 filaments
observed both in vitro and in vivo here appear to be extraneous
but may reveal physical features of relevance to the physiological
properties of the native protein, which could act as a flexible linker
or scaffold within the cell.
The lack of a distinct phenotype in cultured trypanosomes
following the deletion of TbDIP13 suggests a degree of functional
redundancy, with potential compensation by other coiled-coil
proteins with similar structure. However, these results are
surprising given that the single-copy genes encoding orthologues
of SSNA1/DIP13 are present only in the Chordata, protists and
plants. It is possible that the null mutant parasites are defective in
functions that are critical at other stages in the life cycle that are
not easily studied in culture, e.g. during development in the tsetse
fly vector, including parasite meiosis which is non-obligatory and
occurs at very low frequency in T. brucei, most likely in the salivary
glands of the vector [35,36]. The T. brucei Lister 427 BSF strain
used in this study has been extensively cultured and is
monomorphic, having lost the ability to differentiate in the host
from replicating long slender forms to non-dividing short stumpy
forms which are taken up by the tsetse fly [37]. In order to study
the functions of TbDIP13 either in this differentiation process or in
stumpy form parasites, further molecular work will be required
using a pleomorphic strain of T. brucei. In addition, in vitro culture
cannot be used to reproduce parasite differentiation from the
procyclic (PCF) form found in the tsetse midgut through a number
of intermediate forms in the proventriculus to the final host-
infective metacyclic form which resides in the salivary gland of the
insect vector [38]. Assessing the impact of TbDIP13 expression in
these life cycle stages and their production will require
experimental infection of tsetse flies with the generated PCF null
line. In spite of these limitations, we can conclude from our current
data that DIP13 is not required to maintain standard growth rates
and morphology of T. brucei BSF and PCF stages in culture, or to
initiate infection of a mouse model with long slender forms of the
parasite.
As an alternative strategy to elucidate the functions of
TbDIP13, we used comparative proteomic technology to identify
putative binding partners of the protein. A similar application of
this technique has been employed on extracts from T. brucei lines
following RNAi knockdown of the paraflagellar rod (PFR) proteins
and other insoluble flagellar components [39]. We identified a
number of potential interactions, although further validation of
these has been hampered by the tendency of isolated TbDIP13 to
aggregate (data not shown). Further, pulldown studies using this
protein (from over-expressing parasites, E. coli or generated by in
vitro translation) have been challenging due to the harsh buffers
required to maintain the protein in solution. Previous research
showed that human SSNA1 is able to bind to the G-protein
coupled receptor TPRA40 [6] and the microtubule-severing
protein spastin [8]. G-protein coupled receptors are absent from
kinetoplastid genomes [40], while although a homologue of spastin
has been characterised in T. brucei, this is absent from the related
protozoan Leishmania major [41] which has a DIP13 orthologue.
Spastin in T. brucei localises to the nucleus [41] and does not
appear to have complementary functions to TbDIP13. Knock-
down of spastin expression by RNAi has no effect on growth or
morphology, while overexpression of tagged protein results in
nuclear enlargement [41]. Another MT-severing protein in T.
brucei, fidgetin, localises to the nucleus during most of the cell cycle
but relocates to dots, suggested to be kinetochores, on the mitotic
spindle during mitosis [41], in a pattern similar to that of TbDIP13
in PCF cells. RNAi knockdown of a third type of MT-severing
proteins, katenin, in T. brucei causes a significant reduction in
flagellum length in T. brucei, as seen for the DIP13 knockout cell
lines [41]. None of the MT-severing proteins were found in our
proteomic analysis and further investigation is needed to
determine if TbDIP13 is a component of kinetochores and if
there is any functional link between DIP13 and MT-severing
proteins in trypanosomes.
Human SSNA1 and its orthologues are predicted to assume a
coiled-coil conformation, a property shared with several other
autoantigens associated with rheumatic disease, including the
golgin family of Golgi-localised proteins (which are linked to
systemic lupus erythematosus (SLE) and Sjo ¨gren’s syndrome [42])
and the centrosomal protein, pericentrin [43]. The SSNA1 protein
was originally identified as an autoantigen from a single Sjo ¨gren’s
syndrome patient [2] and a recent study showed that 14% of PSS
cases tested positive for autoantibodies against this protein,
compared to 2% or less of patients with other rheumatoid
diseases. Therefore, SSNA1 is believed to be a minor but specific
autoantigen of PSS [3]. The implications of this particular
response and correlation with clinical manifestation are currently
unknown but previous studies have linked autoantibody response
profile to clinical manifestation of rheumatic diseases and may be
used in diagnosis and prognosis [44,45]. SSNA1 and its
orthologues are structurally very similar to a-tropomyosin, which
itself is an autoantigen associated with a subset of patients with the
multi-system inflammatory disease Behc ¸et’s syndrome [46] and a
major allergen associated with responses to invertebrates including
house dust mites, cockroaches and shellfish [47]. Our findings that
TbDIP13 can form stable filaments resembling amyloid fibrils may
have relevance to SSNA1 (and possibly tropomyosin) as an
autoantigen. It is possible that minor populations of patients
showing an SSNA1 autoantibody response may have upregulated
expression of this protein to the level at which aggregation can
occur. Toxic protein aggregation is a common factor of many
neurodegenerative diseases, including Alzheimer’s and Parkinson’s
diseases, and other conditions such as dialysis-related amyloidosis
[48,49]. There is a characteristic accumulation of amyloid deposits
in these disorders but cytotoxicity is believed to be largely due to
intermediate oligomeric species which can be readily taken up into
cells [50]. There are also several potential effects of aggregate
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SSNA1. Protein multimers of over 100 kDa are much more
efficient at inducing an immune response than monomers of low
molecular weight proteins. Insoluble aggregates are more resistant
to degradation, have better engagement with antigen-presenting
cells and result in a more persistent response than soluble species
[51]. Therefore it is likely that an insoluble multimer of SSNA1
would be more immunogenic than a soluble monomer. However,
the antibodies produced may not necessarily recognise the native
monomer, instead showing some specificity for the higher order
structure of the aggregate [51] and potentially cross-reacting with
other similar structures. It is of note in this paper that serum
samples from patients diagnosed with T. brucei rhodesiense infection
contain antibodies that recognise TbDIP13. Further work is
required to assess whether these antibodies cross react with human
SSNA1, which may lead to autoimmune complications in HAT
patients.
Materials and Methods
Bioinformatics
Parasite genome sequence data were obtained from GeneDB
[52] and TriTrypDB [53] resources. DIP13 protein structural
predictions were performed using the Phyre server [15] and
resulting information processed with CCP4mg [54] and Coot [55]
software.
Parasite Culture
The T. brucei bloodstream form strain Lister 427 was maintained
in vitro as described [56]. The procyclic strain EATRO 1125 was
maintained in vitro at 26uC in SDM79 medium [57] containing
10% tetracycline-free fetal bovine serum (Autogen Bioclear).
DNA Constructs
All primer sequences are provided in Table S1. The plasmid
vector pT7-
MYC-C [58,59] was a gift from David Horn and Sam
Alsford (London School of Hygiene and Tropical Medicine,
London, United Kingdom). This vector contains flanking regions
for integration into the transcriptionally silent rDNA spacer
regions of the T. brucei genome and can be used to overexpress the
target gene with a C-terminal myc epitope tag under the control of
a tetracycline-inducible T7 promoter. The complete open reading
frame of the T. brucei DIP13 orthologue (Tb10.61.2720, amino
acids residues 1–195 as annotated GeneDB Version 2.1) was
amplified from genomic DNA using primers DIP-F1 and DIP-R1
and cloned into the plasmid vector pcDNA3.1/CT-GFP TOPO
(Invitrogen). C-terminal GFP-tagged TbDIP13 was then amplified
from the resulting construct, using primers DIP-F2 and DIP-R2,
and cloned into HindIII/XbaI/Klenow fragment treated vector
pT7-
MYC-C to produce construct pTbDIP13
GFP. The TbDIP13
open reading frame (as above) was also amplified using primers
DIP-F3 and DIP-R3, digested with HindIII/XbaI and ligated into
digested pT7-
MYC-C vector to produce the construct pTbDIP13-
myc. In addition, the regions encoding TbDIP13 residues 66–195
and 77–195 were amplified from genomic DNA (using primers
DIP-F4 and DIP-R3; or DIP-F5 and DIP-R3, respectively). Both
fragments were digested with HindIII/XbaI and ligated into
digested pT7-
MYC-C vector as above, to produce the constructs
pTbDIP13-Int
myc and pTbDIP13-Short
myc. A construct for
overexpression of untagged TbDIP13 (pTbDIP13
NoTag) was
produced by the introduction of a stop codon upstream of the
C-terminal myc epitope tag in pTbDIP-Short
myc using the
GeneTailor Site-Directed Mutagenesis System (Invitrogen) and
primers DIP-F6 and DIP-R6.
The RNA interference plasmid vector p2T7Ti was a gift from
Doug LaCount (PULSe, Purdue University, West Lafayette, IN,
USA). A region spanning residues 167–585 of the T. brucei DIP13
open reading frame (as annotated in GeneDB Version 2.1) was
amplified from genomic DNA using the primers DIP-F7 and DIP-
R7, digested with XbaI and cloned into XbaI-digested p2T7Ti [59]
to produce the construct p2T7DIP13.
For production of TbDIP13 null BSF lines, the phleomycin
resistance gene BLE flanked by ACT 59 and 39 untranslated regions
was amplified using primers BLE-F and BLE-R from plasmid
vector pLew82v4 (a gift from George Cross, Laboratory of
Molecular Parasitology, Rockefeller University, New York, USA).
The resulting 1607 bp fragment was cloned into plasmid vector
pCR2.1-TOPO (Invitrogen) to produce the construct pBLE-
TOPO. A 570 bp region of T. brucei genomic DNA beginning
170 bp downstream of the DIP13 ORF (as annotated in GeneDB
Version 2.1) was amplified using primers DIP-F8 and DIP-R8.
The product was digested with XhoI/XbaI and cloned into digested
pBLE-TOPO to produce plasmid pBLE-DIP3UTR. A 564 bp
region beginning 771 bp upstream of the T. brucei DIP13 ORF was
then amplified using primers DIP-F9 and DIP-R9, digested with
SacI/EcoRV and cloned into plasmid pBLE-DIP3UTR to produce
the knockout construct pTbDIPKO-BLE. For replacement of the
second allele of DIP13, pTbDIPKO-BLE was digested with
EcoRV/XhoI to excise the BLE cassette. This was replaced by a
1039 bp fragment encoding the puromycin resistance gene PAC
flanked by 59 ACT and 39 ALD untranslated regions, amplified
from the plasmid vector PHD1034 (a gift from Christine Clayton,
ZMBH, Universitat Heidelberg, Germany) using primers PAC-F
and PAC-R to produce the knockout construct pTbDIPKO-PAC.
For protein expression in E. coli, a fragment spanning residues 77–
195 of the TbDIP13 open reading frame (as annotated in GeneDB
Version 2.1) was amplified from genomic DNA using primers DIP-
F10 and DIP-R10 and cloned into the plasmid vector pET101/D-
TOPO (Invitrogen) to produce the construct pET-DIP13
His.
Antibody Production
The construct pET-DIP13
His was introduced into E.coli BL21
Star (DE3) and expression of recombinant protein was achieved by
induction with 1 mM IPTG for four hours at 30uC. For large-scale
protein purification, cells from 5 L culture were resuspended in
100 ml lysis buffer (8 M urea, 300 mM NaCl, 20 mM sodium
phosphate pH 7.4, 40 mM imidazole and 16Complete protease
inhibitor cocktail, Roche). Cells were lysed by three rounds of
sonication then centrifuged at 50,000 g for 40 minutes at 15uC.
Purification was performed on an AKTA100 (GE) fitted with a
direct loading pump. The clarified lysate was loaded directly onto
an equilibrated 1 ml HisTrap crude column (GE) at a flow rate of
1 ml/minute. Following a 10 column volume (CV) wash with
buffer A (8 M urea, 300 mM NaCl, 20 mM sodium phosphate
pH 7.4, 40 mM imidazole), bound proteins were eluted with
buffer B (8 M urea, 300 mM NaCl, 20 mM sodium phosphate
pH 7.4, 0.5 M imidazole) using a gradient of 0–100% B over 10
CV. Fractions of 1 ml were collected and analysed by SDS-PAGE.
Peak fractions were pooled and TCA precipitated. The pellet was
redissolved in 6 M urea. The protein yield was approximately
2 mg/L cells.
Polyclonal antibodies were produced from two rabbits (Euro-
gentech, 87 day Classic protocol). Antibodies were purified using a
1 ml NHS-activated HP column (GE) coupled to 5 mg of
recombinant TbDIP13 protein. Following column equilibration
with 10 ml binding buffer (20 mM sodium phosphate pH 7.0,
150 mM NaCl), 15 ml rabbit serum was loaded onto the column
at 0.3 ml/minute. Unbound sample was removed with a 5 ml
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elution buffer at low pH (0.1 M glycine pH 2.7, 0.5 M NaCl).
Fractions of 0.5 ml were collected directly into tubes containing
50 ml 1 M Tris-HCl pH 9.0 and analysed by SDS-PAGE. Peak
fractions were pooled and tested by immunoblotting (1:200).
Antibodies against C. reinhardtii DIP13 [4] (a gift from Wolfgang
Mages, Universita ¨t Regensburg, Germany) and human NA14 [2]
(a gift from Rosa Rios Sanchez, CABIMER-CSIC, Seville, Spain)
were also tested on immunoblots containing T. brucei parasite
lysates at a range of concentrations but were unsuitable for further
studies on TbDIP13.
DIP13 Overexpression in T. brucei BSF
The constructs pTbDIP13
GFP, pTbDIP13
myc, pTbDIP13-
Int
myc, pTbDIP13-Short
myc and pTbDIP13
NoTag were transfected
into mid-log phase T. brucei BSF using the NucleofectorH system as
described [60]. Expression of epitope-tagged or untagged DIP13
was induced in stable cell lines by incubating parasites in 1 mg/ml
tetracycline for 0–96 hours. Immunoblotting of total parasite
lysates was performed as described [59]. GFP expression was
analysed by flow cytometry using a Dako CyAn with FL1 detector
and results analysed with Summit v4.3 software.
Splice site Mapping
TRIzol Reagent (Invitrogen) was used to extract total RNA
from parasites (T. b. brucei Lister 427 parental line and cells stably
transfected with pTbDIP-GFP), while total RNA from T. b.
gambiense AnTat 22.1 was a gift from Stijn Deborggraeve and
Veerle Lejon (Department of Parasitology, Institute of Tropical
Medicine, Antwerp, Belgium). RNA samples were treated with
DNase I (Ambion) and reverse-transcribed using Omniscript RT
(Qiagen) and oligo dT. Spliced TbDIP13 transcript was amplified
from first-strand cDNA using primers to the T. brucei spliced leader
sequence [61] and either the 39 end of the DIP13 open reading
frame or GFP C-terminal tag (primers SL-F, DIP-R3 and GFP-
R1, Table S1). Amplified products were cloned into plasmid
vector pCR2.1-TOPO (Invitrogen) and analysed by DNA
sequencing (minimum of 10 clones per cell line).
Knockdown of T. brucei DIP13 by RNA Interference (RNAi)
The construct p2T7DIP13 was linearised with NotI, then
transfected into mid-log phase T. brucei BSF strain Lister 427
and procyclic strain EATRO 1125 using the NucleofectorH system
as described [60]. Stable transformants were selected by growth in
2.5 mg/ml (BSF) or 10 mg/ml (PCF) phleomycin. Production of
dsRNA was induced in stable cell lines by incubating parasites in
1 mg/ml tetracycline.
Production of DIP13 knockout Lines
To generate T. brucei DIP13 null lines (Ddip13::BLE/Ddip13::-
PAC), 5 mg of construct TbDIPKO-BLE was digested with SacI/
XbaI and transfected into BSF strain Lister 427 and PCF strain
EATRO 1125 by nucleofection as above. Stable transformants
were selected by growth in 2.5 mg/ml (BSF) or 10 mg/ml (PCF)
phleomycin. Correct integration of the exogenous DNA fragment
was confirmed by PCR amplification from genomic DNA of a
1067 bp product using primers BLE-KO-F (which anneals to the
ACT 39 UTR) and BLE-KO-R (which anneals to a region of the
DIP13 genomic locus downstream of the predicted integration
site). Cells were then transfected with a second knockout construct,
TbDIPKO-PAC, digested with SacI/BsmI. Stable transformants
were selected by growth in phleomycin as above and 0.5 mg/ml
(BSF) or 1 mg/ml (PCF) puromycin. Clonal populations were
produced by two rounds of limiting dilution in 24-well plates.
Correct integration of the puromycin resistance gene was
confirmed by PCR amplification from genomic DNA of a
1015 bp product using primers PAC-KO-F (which anneals to
the ALD 39 UTR) and PAC-KO-R (which anneals to a region of
the DIP13 genomic locus downstream of the predicted integration
site). Genomic DNA was analysed by Southern blotting using
probes against the DIP13 open reading frame, phleomycin
resistance (BLE) and puromycin (PAC) resistance genes. Clones
were also analysed for the presence of DIP13 by quantitative Real-
Time PCR of genomic DNA, as detailed below. Growth of
confirmed TbDIP13 null cell lines was monitored using a
haemocytometer, diluting cultures to a concentration of 1610
5
cells/ml every 24 hours (BSF) or 1610
6/ml every 48 hours (PCF)
and plotting cumulative numbers. Immunoblotting of total
parasite lysates was performed as described [59].
Quantitative Real-Time PCR
Absolute quantitation by qPCR was used to determine changes
in DIP13-specific transcript following tetracycline induction of
RNAi, relative to a constitutively expressed control, either a-
tubulin or myristoyl-CoA:protein N-myristoyltransferase (NMT).
Total RNA was extracted from parasites using Trizol reagent
(Invitrogen) as described by the manufacturer. Traces of genomic
DNA were removed by treatment with DNase I, prior to reverse
transcription using Omniscript RT (Qiagen) and Oligo-dT
(Promega). Alternatively, qPCR was used as a highly sensitive
method to confirm the absence of TbDIP13 in the genomic DNA
of clonal populations of DIP13 null parasite lines, compared to two
other genes from the same chromosome (10): myristoyl-CoA:pro-
tein N-myristoyltransferase (NMT) and ARL2. The program
Primer Express (Applied Biosystems) was used to design the
following primers: DIP-qPCR-F, DIP-qPCR-R, NMT-qPCR-F,
NMT-qPCR-R, ARL2-qPCR-F, ARL2-qPCR-R, aTUB-qPCR-F
and aTUB-qPCR-R (Table S1). Quantitative PCR reactions were
performed using SYBR Green Mastermix (Applied Biosystems) on
an ABI 7000 Sequence Detection System (Applied Biosystems)
and results analysed with Sequence Detection Software v1.2.3
(Applied Biosystems).
Confocal Microscopy
Indirect immunofluorescence assays on parasites were per-
formed as described [59]. Primary antibodies were used as follows:
mouse monoclonal antibodies L13D6 against PFR1/2 and TAT1
against T. brucei a-tubulin (1:50 and 1:200 dilution respectively,
gifts from Keith Gull, Sir William Dunn School of Pathology,
University of Oxford, UK), mouse monoclonal 6-11B-1 against
acetylated a-tubulin (1:200, Sigma), rabbit anti-TbRab5A (1:250,
a gift from Mark Field, Department of Pathology, University of
Cambridge, UK) and mouse anti-myc (1:250, Invitrogen). Rabbit
anti-TbDIP13 (described above) was used at 1:20 dilution for
immunofluorescence analysis. Primary antibodies were detected
using Alexa Fluor 488 or 633 conjugated secondary antibodies
(Invitrogen). Co-localization with rhodamine-labelled ConA
(Sigma) was performed on ice or at 37uC for 10 minutes, using
methods described previously [59]. Samples were visualized by
confocal microscopy using a Zeiss LSM 510 meta with a Plan-
Apochromat 636/1.4 Oil DIC I objective lens and images
acquired using LSM 510 version 3.2 software (Zeiss). Cell body
(posterior end of the body to the flagellum tip) and PFR lengths
(100 per sample) were measured from acquired images using LSM
software as above. Statistical analysis (1 way ANOVA) was
performed using GraphPad Prism 4.
SSNA1/DIP13 in Trypanosoma brucei
PLoS ONE | www.plosone.org 11 February 2012 | Volume 7 | Issue 2 | e31842Electron Microscopy
Transmission electron microscopy of parasites was performed as
described [62]. For scanning electron microscopy of intact
parasites, 2610
7 log-phase cells (grown +/2 tetracycline for
24 hours) were washed in PBS before settling onto poly L-lysine
coated Thermanox coverslips (Nunc). After washing in PBS, cells
were fixed in 1% gluteraldehyde for 1 hour then washed twice for
30 minutes in 100 mM phosphate buffer. All steps were
performed in microcentrifuge tubes, briefly centrifuged and
resuspended between each step. Cells were then dehydrated by
suspending in an ethanol series of 50%, 70%, 90%, 100% for
30 minutes at each step, before addition of hexamethyl disilazane
(HMDS) for 30 minutes. Cells were then air dried overnight. The
pellet was vortexed, mounted on aluminium SEM stubs, coated
with a thin layer (,7 nm) of gold/palladium and visualised on a
JEOL JSM-649OLV scanning electron microscope at 8 kV, spot
size 35. For SEM of detergent-extracted cytoskeletons, cells were
settled onto coverslips, then treated with 1% Triton-X/PBS at RT
for 10 minutes, before fixing and processing as above.
For immuno-staining of cytoskeletons, cells were settled onto
coverslips and detergent-extracted as above. Samples were
incubated in blocking solution (1% fatty acid free BSA/PBS) for
30 minutes, then in primary antibody (rabbit anti-GFP, AbCam)
diluted 1:200 in blocking solution for 15 minutes. Coverslips were
washed three times in blocking buffer, incubated in 4%
paraformaldehyde for 20 minutes then washed three times in
20 mM glycine/PBS and once in blocking buffer. Samples were
incubated in 10 nM gold conjugated goat anti-rabbit IgG (Agar
Scientific) diluted 1:10 in blocking buffer for 30 minutes then
washed four times in blocking buffer. Cells were then fixed in 2.5%
glutaraldehyde/PBS before dehydration and carbon coating as
above. Samples were visualised on a JEOL JSM-7500F scanning
electron microscope with backscattered electron detector.
For transmission electron microscopy of oligomerised protein,
purified recombinant TbDIP13
His produced in E. coli (as described
above, 10 mg/ml in 6 M urea) was diluted 1:10 with 30 mM
MOPS pH 7.0, incubated for 24 hours at 37uC, then diluted 1:10
again to a final protein concentration of 0.1 mg/ml. A drop of
suspension (8 ml) was placed on a 200 mesh copper grid with a
Formvar/carbon support film for 2 minutes at room temperature,
then stained with 1% uranyl acetate in water for 10 minutes.
Viewing was at 120 kV with a Tecnai 12 BioTwin (FEI) and
images captured with a SIS Megaview III digital camera.
Immunoblotting with Human African Trypanosomiasis
(HAT) patient sera
Immunoblots were prepared containing 30 ng of purified
recombinant TbDIP13 protein (from E. coli as described above)
or total lysate from 1610
6 T. brucei BSF Lister 427 parasites per
lane. Blots were probed individually with 10 human serum
samples collected in 2002–03 from Uganda [63], comprising 8
confirmed T. b. rhodesiense cases (including both early and late
stages of the disease) and 2 uninfected controls. Blots were probed
with sera diluted 1:400 in blocking buffer (5% milk, 0.1% Tween-
20 in PBS) then with horseradish peroxidase labelled goat anti
human IgG (Sigma) diluted 1:25,000 in blocking buffer. Signals
were detected using ECL Plus reagents (GE Healthcare Life
Sciences).
Mouse Infections
Animal experiments were performed at the University of
Cambridge in strict accordance with the UK Home Office
Animal [Scientific Procedures] Act 1986, following approval by
the University of Cambridge Ethical Review Panel, PPL number
80/2314. Swiss outbred (CD-1) mice were infected by i.p. injection
with 2610
5 parasites of the T. brucei BSF parental Lister 427 or
DIP13 double knockout cell line. Parasitaemia was measured at
48 hours and 72 hours by microscopy analysis of tail-cut blood
samples and the experiment terminated at the later timepoint.
Comparative proteomics (iTRAQ) of flagellar extracts
Flagellar fractions were prepared from T. brucei BSF lines
Lister 427 and lines stably transfected with pTbDIP13
GFP or
pTbDIP13
myc following incubation in tetracycline for 24 hours.
Protein samples were subjected to trypsin digestion and labelled
using iTRAQ reagents (Applied Biosystems). Fractions were
separated by Strong Cation Exchange chromatography and
analysed by Nano-LC-ESI-MS. Full detailsare provided inMethods
S1. Identified proteins and corresponding peptide sequences have
been deposited with TriTrypDB (www.tritrypdb.org).
Supporting Information
Figure S1 Splice site analysis of T. brucei DIP13. (A)
Alignment of kinetoplastid DIP13 orthologues and related protein
sequences. Sequence accession numbers (EMBL/TryTrypDB):
Mouse, CAM14679.1; Human, O43805; Schistosoma mansoni,
CAZ279931.1; Chlamydomonas reinhardtii, EDP00400.1; Eimeria tenella,
CAK51393.1; Plasmodium falciparum, CAX64385.1; Trypanosoma brucei
gambiense, Tbg972.10.16480; Trypanosoma brucei brucei, Tb10.61.2720
(now Tb927.10.14110); Trypanosoma cruzi, Tc00.1047053507993.369;
Leishmania major, LmjF34.4540; Leishmania infantum, LinJ34_V3.4170;
Leishmania braziliensis, LbrM20_V2.4000. (B) DNA sequence
alignment of T. b. brucei and T. b. gambiense DIP13 loci. The
original annotated start codons for T. b. brucei and T. b. gambiense
are shown in red and dark green boxes, respectively, and the
stop codon in a grey box. The two annotated sequences differed
by the apparent insertion of a single nucleotide (shown in an
orange box) in T. b. gambiense. However, this insertion was found
in some but not all of the T. b. brucei sequences. We performed
splice site mapping by RT-PCR using primers to the splice
leader sequence and the 39 region of the DIP13 ORF. The
amplified products were cloned and DNA sequenced to find the
position of the splice leader sequence within the DIP13 gene.
The trans-splicing acceptor site (AG) was mapped to 202 bases
downstream of the annotated start codon in T. b. brucei and was
in the same position in the T. b. gambiense DIP13 sequence
(marked by a light green box). We also found the annotated T.
b. gambiense start codon (dark green box) to be ACG in all
sequenced clones from both subspecies. This information was
used to identify the correct start codons in the T. b. brucei and
T. b. gambiense genes (dark blue box), both of which correspond
to those of the other DIP13 orthologues. (C) Sequence of the
correct T. brucei DIP13 ORF, with predicted coiled-coil shown
in red text. (D, E) Expression of different ‘splice variants’ of T.
b. brucei DIP13 fused to a C-terminal myc tag. Constructs
encoding the DIP13 ORF were generated in a myc tag vector,
starting at the original annotated start codon (B above, red box)
with no insertion at nucleotide position 76; the T. b. gambiense
original annotated start codon (B, dark green box, sequence
changed to ATG) or the elucidated start codon (B, dark blue
box). Isoforms were named Long, Intermediate (Int) or Short,
respectively. (D) Immunofluorescence of T. b. brucei BSF Lister
427 transfected with each of the three constructs and incubated
in the presence of tetracycline for 24 hours. Cells were probed
with mouse anti-myc and detected with Alexa Fluor 488
conjugated goat-anti-mouse (green). All cells were co-stained
SSNA1/DIP13 in Trypanosoma brucei
PLoS ONE | www.plosone.org 12 February 2012 | Volume 7 | Issue 2 | e31842with DAPI (blue). Bar, 5 mm. (E) Total cell lysates (1610
7 cells/
lane) from BSF parental line Lister 427 (wt) and cells as in D,
grown in the presence of tetracycline for 24 hours, were
immunoblotted and probed with mouse anti-myc and anti-BiP
to monitor equal sample loading. L, Long isoform, I,
Intermediate, S, Short isoform. The data show that the Long
and Short isoforms produced proteins of the same size and
subcellular localisation, corresponding to use of the elucidated
endogenous splice acceptor site and correct start codon. The
Intermediate isoform protein is slightly larger in size and has a
different subcellular localisation, consistent with a short N-
terminal extension but use of the same splice acceptor site as
above. We conclude that the DIP13 gene preferentially uses the
splice acceptor site shown in B above, regardless of the presence
of an upstream splice site in the expression vector. RT-PCR was
also performed on material from BSF cells expressing the ‘Long’
isoform of DIP13 with a C-terminal GFP tag (data not shown).
All clones utilised the endogenous splice acceptor site,
supporting our findings for the myc-tagged isoforms.
(TIF)
Figure S2 Detection of DIP13
GFP by scanning immuno-
electron microscopy. T. brucei BSF parasites of transgenic line
427/pTbDIP13GFP were incubated in the presence of tetracy-
cline for 24 hours, then extracted with 1% Triton X-100, probed
with rabbit anti-GFP (Abcam) and detected with 10 nm colloidal
gold conjugated goat-anti-rabbit. Scanning electron micrographs
are shown in (A) and (C) and immuno-electron micrographs of
selected regions (marked by yellow boxes) are shown in (B) and (D).
Areas containing gold particles are indicated by yellow arrows. Fl,
flagellum. Bar, 1 mm (A, C) or 200 nm (B, D).
(TIF)
Figure S3 Scanning electron micrographs of DIP13
GFP-
expressing cells. (A, B) Scanning electron micrographs of intact
T. brucei BSF lines Lister 427 (A) and 427/pTbDIP13GFP
24 hours post-induction (B). Both images show the region of the
cell where the flagellum emerges from the flagellar pocket. (C, D)
Scanning electron micrographs of BSF cells following extraction
with 1% Triton X-100. (C) Lister 427 parental line, (D) 427/
pTbDIP13GFP 24 hours post-induction, with an extraneous
structure indicated by yellow arrows. Bars as shown.
(TIF)
Figure S4 Comparative proteomics (iTRAQ) of T.
brucei BSF flagellar extracts. (A) Flagellar extracts (10 mg)
from T. brucei BSF parental line Lister 427 (1) and transgenic BSF
lines 427/ pTbDIP13GFP (2) and 427/ pTbDIP13myc (3) were
separated by SDS-PAGE and stained with Sypro Ruby.
Corresponding protein marker positions are shown (kDa). (B) Plot
to show the reproducibility of iTRAQ ratio determination. The
number of peptide events for each identified protein is plotted
against the observed protein ratio for two experimental replicates
of extracts from TbDIP13
myc expressing cells labelled with either
113 or 117 iTRAQ isobaric tags. Based on these data, proteins
with less than 4 peptide events were excluded from further analysis
(C) Plot as above to show the observed protein ratios for
TbDIP13
myc expressing cells (113 tag) compared to parental
control extract (114 tag).
(TIF)
Table S1 List of primer sequences.
(DOC)
Table S2 List of proteins identified in the flagellar extracts of T.
brucei BSF cells with pI value less than 10.5.
(DOC)
Table S3 List of proteins identified in the flagellar extracts of T.
brucei BSF cells with pI value greater than 10.5.
(DOC)
Table S4 List of proteins significantly enriched or depleted in
the flagellar extracts of T. brucei BSF overexpressing DIP13
compared to the parental line.
(DOC)
Methods S1 Additional methods for comparative proteomic
studies.
(DOC)
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